What determines mortality and morbidity rates in non-variceal, non-malignant upper gastrointestinal bleeding treated with urgent surgical operation?

Acil cerrahi operasyonla tedavi edilen varis dışı, malign olmayan üst gastrointestinal kanamalarda mortalite ve morbidite oranlarını ne belirler?

Authors

  • Haldun Kar
  • Necat Cin
  • Yasin Peker
  • Evren Durak
  • Halis Bağ
  • Cengiz Tavusbay
  • Fevzi Cengiz

Abstract

Despite the advances in treatment modalities, upper gastrointestinal (GI) bleeding is still a significant health issue. We aimed to assess the risk factors on mortality and morbidity rates in the patients that underwent surgery due to non-variceal and non-malignant bleeding from upper gastrointestinal tract.

We retrospectively examined records of 127 cases with non-variceal, non-malignant acute upper GI bleeding in the our University Hospital, General Surgery Clinic between January 1996 and December 2014.

Median age was 60 (16-88) years. The most frequent cause of upper gastrointestinal bleeding was duodenal ulcer observed in 93 (73.23%) patients. The most frequent presenting complaint was melena and hematemesis observed in 66 (52%) patients. Primary suturing, bilateral truncal vagotomy and pyloroplasty were the most frequent surgical procedure performed in 79 (62.20%) patients. There were 23 (27.71%) mortalities.

Statistically, mortality and morbidity rates were found to be significantly associated with female sex (OR 6.517, 95% CI 1.559 to 27.238, p=0.010), hematemesis at presentation (OR 10.378, 95% CI 1.889 to 57.005, p=0.007), presence of comorbidity (OR 14.131, 95% CI 2.197 to 90.904, p=0.005), and high urea levels (OR 0.937, 95% CI 0.952 to 0.994, p=0.013) prior to operation.

In conclusion, although surgical treatment is the most effective method to control active bleeding from the ulcer and to prevent recurrence, it is often associated with high mortality and morbidity risk due to comorbidities; therefore it should be spared for cases for whom endoscopic and interventional radiologic treatment modalities is unsuccessful.

ÖZET

Tedavi modalitelerindeki gelişmelere rağmen üst gastrointestinal (GI) kanamalar hala önemli bir sağlık sorunudur. Üst gastrointestinal sistemden varis dışı ve malign olmayan kanama nedeniyle ameliyat edilen hastalarda mortalite ve morbidite oranları etkileyen risk faktörlerini değerlendirmeyi amaçladık.

Üniversite Hastanemiz Genel Cerrahi Kliniğinde varis dışı, malign olmayan akut üst GİS kanaması olan 127 olgunun kayıtları geriye dönük olarak incelendi.

Medyan yaş 60 (16-88) idi. Üst gastrointestinal kanamanın en sık nedeni 93 (%73.23) hastada görülen duodenum ülseri idi. En sık başvuru şikayeti 66 (%52) hastada görülen melena ve hematemez idi. 79 (%62.20) hastada en sık uygulanan cerrahi işlem primer sütür, bilateral trunkal vagotomi ve piloroplasti idi. 23 (%27.71) hastada exitus gelişdi. İstatistiksel olarak, mortalite ve morbidite oranlarının kadın cinsiyet (OR 6.517, %95 CI 1.559 ila 27.238, p=0.010), başvuru sırasındaki hematemez (OR 10.378, %95 CI 1.889 ila 57.005, p=0.007), komorbidite varlığı (OR 14.131, %95 CI 2.197 ila 90.904, p=0.005) ve operasyondan önceki yüksek üre seviyeleri (OR 0.937, %95 CI 0.952 ila 0.994, p=0.013) ile anlamlı şekilde ilişkili olduğu bulundu.

Cerrahi tedavi, ülserden aktif kanamayı kontrol altına almak ve nüks kanamayı önlemek için en etkili yöntem olmasına karşın, sıklıkla eşlik eden komorbiditeler nedeniyle yüksek mortalite ve morbidite riski ile ilişkilidir; bu nedenle endoskopik ve girişimsel radyolojik tedavi yöntemlerinin başarısız olduğu olgularda tercih edilmelidir.

 

Author Biography

Haldun Kar

İKÇÜ, Atatürk EA Hastanesi,

İzmir, Türkiye

References

Biecker E. Diagnosis and therapy of non-variceal upper gastrointestinal bleeding. World J Gastrointest Pharmacol Ther 2015;6:172-182.

Stanley AJ, Laine L. Management of acute upper gastrointestinal bleeding. BMJ 2019; 364: l536.

Telaku S, Kraja B, Qirjako G, Prifti S, Fejza H. Clinical outcomes of nonvariceal upper gastrointestinal bleeding in Kosova. Turk J Gast-roenterol 2014;25:110-115.

Skok P, Sinkovic A. Upper gastrointestinal hemorrhage: predictive factors of in-hospital mortality in patients treated in the medical ıntensive care unit. J Int Med Res 2011;39:1016-1027.

Szura M, Pasternak A. Upper gastrointestinal bleeding - state of the art. Folia Med Cracov 2014;54:59-78.

Botianu A, Matei D, Tantau M, Acalovschi M. Mortality and need of surgical treatment in acute upper gastrointestinal bleeding: a one year study in a tertiary center with a 24 hours/day - 7 days/week endoscopy call. Has anything changed? Chirurgia (Bucur) 2013;108:312-318.

Özen E, Tekin F, Oruç N, Özütemiz Ö, Aydın A, Günşar F, et al. Varis dışı üst gastrointesti-nal sistem kanamalı 412 olgunun irdelenmesi. Akademik Gastroenteroloji Dergisi 2007;6:62-67.

Rockall TA, Logan RF, Devlin HB, Northfield TC. Risk assessment after acute upper gastro-intestinal haemorrhage. Gut 1996;38:316-321.

Önder A, Kapan M, Taşkesen F, Aliosmanoğlu İ, Arıkanoğlu Z, Gül M. Cerrahi tedavi uygu-lanan varis-dışı ve malignite-dışı üst gastroin-testinal sistem kanamalarında mortaliteyi et-kileyen faktörler. Ulusal Cerrahi Dergisi 2011;27:216-221.

Yalçın M, Kara B, Öztürk NA, Ölmez Ş, Taş-doğan BE, Taş A. Epidemiology and Endoscopic Findings of the Patients Suffering from Upper Gastrointestinal System Bleeding. Dic-le Tıp Dergisi 2016;43:73-76.

Higashiyama M, Suzuki H, Watanabe C, Tomita K, Komoto S, Nagao S, et al. Lethal hemorrhage from duodenal ulcer due to small pancreatic cancer. Clin J Gastroenterol 2015;8:236-239.

Mille M, Engelhardt T, Stier A. Bleeding Duodenal Ulcer: Strategies in High-Risk Ulcers. Visc Med 2021;37:52-62.

Wilkins T, Khan N, Nabh A, Schade RR. Di-agnosis and management of upper gastrointestinal bleeding. Am Fam Physician 2012;85:469-476.

Lu M, Sun G, Zhang XL, Zhang XM, Liu QS, Huang QY, et al. Risk factors associated with mortality and increaseddrug costs in nonvariceal upper gastrointestinal bleeding. Hepato-gastroenterology 2015;62:907-912.

Kaplan RC, Hecbert SR, Psaty BM. Risk factors for hospitalized upper or lower gastrointestinal tract bleeding in treated hypertensives. Prev Med 2002;34:455-462.

Gralnek IM, Dumonceau JM, Kuipers EJ, Lanas A, Sanders DS, Kurien M, et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage. European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015;47:a1.

Cipolletta L, Bianco MA, Rotondano G, Marmo R, Piscopo R. Outpatient management for low-risk nonvariceal upper gastrointestinal bleeding: a randomized controlled trial. Gastrointest Endosc 2002;55:1-5.

Gralnek IM, Stanley AJ, Morris AJ, Camus M, Lau J, Lanas A, et al. Endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage (NVUGIH): European Society of Gastrointestinal Endoscopy (ES-GE) Guideline - Update 2021. Endoscopy 2021;53:300-332.

Akıncı H, Yücel T, Kuroğlu E, Özkan-Gürdal S. Varis dışı üst gastrointestinal sistem kana-malarında cerrahi ve konservatif tedavi için hasta seçiminde dikkate alınacak noktalar. Ulusal Travma ve Acil Cerrahi Dergisi 2004;10:226-231.

Tomizawa M, Shinozaki F, Hasegawa R, Shi-rai Y, Motoyoshi Y, Sugiyama T, et al. Patient characteristics with high or low blood urea nitrogen in upper gastrointestinal bleeding. World J Gastroenterol 2015;21:7500-7505.

Samuel R, Bilal M, Tayyem O, Guturu P. Evaluation and management of non-variceal upper gastrointestinal bleeding. Dis Mon 2018;64:333-343.

Dango S, Beißbarth T, Weiss E, Seif Amir Hosseini A, Raddatz D, Ellenrieder V, et al. Relevance of surgery in patients with non-variceal upper gastrointestinal blee-ding. Langenbecks Arch Surg 2017;402:509-519.

Lee CW, Sarosi GA. Emergency ulcer surgery. Surg Clin North Am 2011;91:1-12.

Downloads

Published

2022-08-29

Issue

Section

Articles